CSS
CUE icon

Cubist Systematic Strategies’s Cue Biopharma CUE Stock Holding History

Cubist Systematic Strategies’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-122
Closed -$3.99K – 2971
2024
Q4 		$3.99K Buy
+122
New +$4.58K ﹤0.01% 2881
2024
Q3 		– Sell
-138
Closed -$5.14K – 3066
2024
Q2 		$5.14K Buy
+138
New +$6.83K ﹤0.01% 2825
2023
Q2 		– Sell
-1,344
Closed -$144K – 3645
2023
Q1 		$144K Sell
1,344
-2
-0.1% -$191 ﹤0.01% 3357
2022
Q4 		$115K Hold
1,346
– – ﹤0.01% 3767
2022
Q3 		$90K Sell
1,346
-726
-35% -$62.5K ﹤0.01% 4042
2022
Q2 		$155K Buy
2,072
+1,184
+133% +$138K ﹤0.01% 3798
2022
Q1 		$130K Buy
+888
New +$188K ﹤0.01% 3169
2021
Q4 		– Sell
-441
Closed -$193K – 3489
2021
Q3 		$193K Sell
441
-430
-49% -$150K ﹤0.01% 2596
2021
Q2 		$304K Buy
+871
New +$338K ﹤0.01% 2320
2021
Q1 		– Sell
-391
Closed -$147K – 2851
2020
Q4 		$147K Buy
+391
New +$156K ﹤0.01% 2343
2020
Q3 		– Sell
-724
Closed -$532K – 2511
2020
Q2 		$532K Buy
+724
New +$524K 0.01% 1559

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cubist Systematic Strategies's CUE Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Cue Biopharma (CUE) in Q1 2025, closing a stake of 122 shares — an estimated $3.99K sold.

Cubist Systematic Strategies first reported a position in CUE in Q2 2020 and held it in 11 quarters. The position peaked at $532K in Q2 2020. 49 funds tracked by Wall St. Rank hold CUE as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Cue Biopharma position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 122 Cue Biopharma shares in Q1 2025, an estimated $3.99K.
  • Cubist Systematic Strategies first reported a position in Cue Biopharma in Q2 2020 and held it in 11 quarters.
  • Cubist Systematic Strategies's Cue Biopharma position peaked at $532K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.